Home/Filings/4/0001104659-21-068838
4//SEC Filing

Ammer Richard 4

Accession 0001104659-21-068838

CIK 0001824293other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 4:08 PM ET

Size

7.8 KB

Accession

0001104659-21-068838

Insider Transaction Report

Form 4
Period: 2021-05-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-05-14+15,00015,000 total
    Exercise: $3.66Exp: 2031-05-14Common Stock (15,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-05-14+10,20410,204 total
    Exercise: $3.66Exp: 2031-05-14Common Stock (10,204 underlying)
Footnotes (2)
  • [F1]The stock option vests in 24 equal monthly installments such that the stock option is fully vested on the second annual anniversary of the date of grant.
  • [F2]The stock option vests as to 50% of the underlying shares of common stock on June 30, 2021, then in two equal installments on September 30, 2021 and December 31, 2021, such that the stock option fully vests on December 31, 2021.

Issuer

Vallon Pharmaceuticals, Inc.

CIK 0001824293

Entity typeother

Related Parties

1
  • filerCIK 0001843671

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:08 PM ET
Size
7.8 KB